1-3 of 3
Muhammad Arshad, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Feasibility Study of Temozolomide Maintenance Therapy in Elderly Patients with AML Following Induction Therapy with High Dose Mitoxantrone and High Dose Ara-C.

Sreedhar Katragadda, MD, Muhammad Arshad, MD, Delong Liu, MD PhD, Nasir Ahmed, MD, Quihu Shi, PhD, Tauseef Ahmed, MD, Karen Seiter, MD
Journal: Blood
Blood (2006) 108 (11): 4546.
https://doi.org/10.1182/blood.V108.11.4546.4546
Published: 2006
Journal Articles

High-Dose Mitoxantrone-Based Induction Therapy in Newly-Diagnosed AML. Results of 171 Patients Treated at NYMC between 1991–2003.

Karen Seiter, MD, Delong Liu, MD, PhD, Eric Feldman, MD, Qiuhu Shi, PhD, Paul Baskind, Muhammad Arshad, MD, Anila Qureshi, MD, Tauseef Ahmed, MD
Journal: Blood
Blood (2005) 106 (11): 1859.
https://doi.org/10.1182/blood.V106.11.1859.1859
Published: 2005
Journal Articles

Phase II Study of Gemtuzumab Ozogamycin (GO) and Cytarabine (ARA-C) in Patients with High Risk MDS and AML..

Peter Kang, MD, Karen Seiter, MD, Delong Liu, MD, PhD, Muhammad Arshad, MD, Anila Qureshi, MD, John Nelson, MD, Tauseef Ahmed, MD
Journal: Blood
Blood (2004) 104 (11): 4723.
https://doi.org/10.1182/blood.V104.11.4723.4723
Published: 2004